Revolution Medicines, Inc. · NASDAQ:RVMD

Goldsmith Mark A sold 13,988 Revolution Medicines, Inc. shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 18, 2026

On Sep 16, 2026, Goldsmith Mark A (Director, See Remarks) sold 13,988 Revolution Medicines, Inc. shares at an average US$199.23 for US$2.79M under a trading plan, leaving 253,342 shares. Filed Sep 18, 2026 (Form 4).

Sold
13,988 shares
Price
US$199.23 average (US$195.01 to US$199.30)
Value
US$2.79M
Holding after
253,342 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockSale213US$195.01267,117Direct
Sep 16, 2026Common StockSale13,775US$199.30253,342Direct

Source

View original at SEC

Related